Alligator Bioscience AB (publ) (STO: ATORX)
Sweden
· Delayed Price · Currency is SEK 0.503
-0.076 (-13.13%)
Nov 20, 2024, 5:29 PM CET
Alligator Bioscience AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -248.31 | -248.59 | -193.4 | -141.74 | -143.3 | -210.11 | Upgrade
|
| Depreciation & Amortization | 9.53 | 10.43 | 11.31 | 12.31 | 11.39 | 11.43 | Upgrade
|
| Other Amortization | 0.06 | 0.06 | 0.13 | 0.13 | 0.13 | 0.12 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.32 | -1.3 | - | - | Upgrade
|
| Stock-Based Compensation | 0.08 | 0.07 | 0.1 | 0 | 0.04 | 0.3 | Upgrade
|
| Other Operating Activities | -0.26 | 1 | -0.05 | - | -1.13 | -3.07 | Upgrade
|
| Change in Accounts Receivable | 6.84 | 13.27 | -5.86 | -13.59 | 2.12 | 25.29 | Upgrade
|
| Change in Other Net Operating Assets | -1.14 | 34.47 | 14.84 | 17.14 | -10.61 | -5.05 | Upgrade
|
| Operating Cash Flow | -233.19 | -189.29 | -172.61 | -127.03 | -141.35 | -181.09 | Upgrade
|
| Capital Expenditures | - | -2.46 | -0.44 | -0.05 | -0.1 | -2.07 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.12 | Upgrade
|
| Investment in Securities | - | - | - | - | 156.99 | 170 | Upgrade
|
| Investing Cash Flow | - | -2.46 | -0.44 | -0.05 | 156.89 | 167.82 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.78 | Upgrade
|
| Long-Term Debt Repaid | - | -9.75 | -7.91 | -6.97 | -6.15 | -7.08 | Upgrade
|
| Net Debt Issued (Repaid) | 71.51 | -9.75 | -7.91 | -6.97 | -6.15 | -6.3 | Upgrade
|
| Issuance of Common Stock | 98.06 | 195.54 | 0.38 | 342.67 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -0.38 | - | - | - | Upgrade
|
| Other Financing Activities | 38.27 | -24.22 | 0.08 | -33.9 | - | 0 | Upgrade
|
| Financing Cash Flow | 207.84 | 161.56 | -7.83 | 301.8 | -6.15 | -6.3 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.77 | -1 | 0.03 | 0.06 | 0.15 | 1.44 | Upgrade
|
| Net Cash Flow | -26.12 | -31.19 | -180.84 | 174.78 | 9.53 | -18.13 | Upgrade
|
| Free Cash Flow | -233.19 | -191.74 | -173.05 | -127.08 | -141.45 | -183.16 | Upgrade
|
| Free Cash Flow Margin | -839.61% | -323.61% | -480.67% | -953.54% | -2564.90% | -4202.80% | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.43 | -0.78 | -1.42 | -1.98 | -2.57 | Upgrade
|
| Cash Interest Paid | 4.02 | 0.48 | 0.65 | 0.24 | 0.35 | 0.42 | Upgrade
|
| Levered Free Cash Flow | -65.96 | -100.16 | -98.69 | -74.03 | -87.3 | -103.24 | Upgrade
|
| Unlevered Free Cash Flow | -59.44 | -99.86 | -98.29 | -73.89 | -87.1 | -102.97 | Upgrade
|
| Change in Net Working Capital | -80.87 | -47.91 | -10.8 | -2.24 | 8.54 | -20.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.